Verona Pharma PLC (VRNA)
15.73
+0.51
(+3.35%)
USD |
NASDAQ |
May 02, 16:00
15.80
+0.07
(+0.45%)
Pre-Market: 08:36
Verona Pharma Price to Book Value: 5.100 for May 2, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 5.100 |
| May 01, 2024 | 4.934 |
| April 30, 2024 | 5.009 |
| April 29, 2024 | 5.044 |
| April 26, 2024 | 5.015 |
| April 25, 2024 | 4.963 |
| April 24, 2024 | 4.941 |
| April 23, 2024 | 5.054 |
| April 22, 2024 | 5.096 |
| April 19, 2024 | 5.096 |
| April 18, 2024 | 5.220 |
| April 17, 2024 | 5.317 |
| April 16, 2024 | 5.252 |
| April 15, 2024 | 5.122 |
| April 12, 2024 | 5.158 |
| April 11, 2024 | 5.242 |
| April 10, 2024 | 5.275 |
| April 09, 2024 | 5.339 |
| April 08, 2024 | 5.472 |
| April 05, 2024 | 5.518 |
| April 04, 2024 | 5.362 |
| April 03, 2024 | 5.262 |
| April 02, 2024 | 5.164 |
| April 01, 2024 | 5.203 |
| March 28, 2024 | 5.216 |
| Date | Value |
|---|---|
| March 27, 2024 | 5.349 |
| March 26, 2024 | 5.232 |
| March 25, 2024 | 5.093 |
| March 22, 2024 | 5.210 |
| March 21, 2024 | 5.171 |
| March 20, 2024 | 5.164 |
| March 19, 2024 | 4.960 |
| March 18, 2024 | 5.035 |
| March 15, 2024 | 5.074 |
| March 14, 2024 | 5.038 |
| March 13, 2024 | 5.411 |
| March 12, 2024 | 5.343 |
| March 11, 2024 | 5.158 |
| March 08, 2024 | 5.262 |
| March 07, 2024 | 5.424 |
| March 06, 2024 | 5.453 |
| March 05, 2024 | 5.498 |
| March 04, 2024 | 5.602 |
| March 01, 2024 | 5.897 |
| February 29, 2024 | 5.583 |
| February 28, 2024 | 5.596 |
| February 27, 2024 | 5.806 |
| February 26, 2024 | 5.716 |
| February 23, 2024 | 5.346 |
| February 22, 2024 | 5.421 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6654
Minimum
Mar 18 2020
21.24
Maximum
Jul 22 2020
3.789
Average
2.414
Median
Jun 15 2021
Price to Book Value Benchmarks
| NuCana PLC | 0.4421 |
| TC BioPharm (Holdings) PLC | 1.354 |
| Biodexa Pharmaceuticals Plc | 0.9161 |
| Adaptimmune Therapeutics PLC | 7.434 |
| Bicycle Therapeutics PLC | 2.521 |
Price to Book Value Related Metrics
| Price | 15.73 |
| Earnings Yield | -4.58% |
| Market Cap | 1.271B |